Chemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's Disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cell Stem Cell

• Publication date

  2016-06-02

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.stem.2016.03.014PMID 27133795PMCID PMC4892985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.

  2015cited by this paper
• Optogenetics enables functional analysis of human embryonic stem cell–derived grafts in a Parkinson's disease model

  2015cited by this paper
• Human ESC-Derived Dopamine Neurons Show Similar Preclinical Efficacy and Potency to Fetal Neurons when Grafted in a Rat Model of Parkinson’s Disease

  2014cited by this paper
• Remote control of induced dopaminergic neurons in parkinsonian rats.

  2014cited by this paper
• Chemogenetic tools to interrogate brain functions.

  2014cited by this paper
• hPSC-derived maturing GABAergic interneurons ameliorate seizures and abnormal behavior in epileptic mice.

  2014cited by this paper
• l-DOPA and graft-induced dyskinesia: Different treatment, same story?

  2013cited by this paper
• Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease.

  2013cited by this paper
• Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice.

  2012cited by this paper
• Long-distance growth and connectivity of neural stem cells after severe spinal cord injury.

  2012cited by this paper
• Generation of regionally specified neural progenitors and functional neurons from human embryonic stem cells under defined conditions.

  2012cited by this paper
• A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

  2012cited by this paper
• Dopaminergic modulation of synaptic transmission in cortex and striatum.

  2012cited by this paper
• Specification of Midbrain Dopamine Neurons from Primate Pluripotent Stem Cells

  2012cited by this paper
• Unilateral nigrostriatal 6-hydroxydopamine lesions in mice I: motor impairments identify extent of dopamine depletion at three different lesion sites.

  2012cited by this paper
• Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD

  2011cited by this paper
• Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids

  2010cited by this paper
• Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors.

  2009cited by this paper
• Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand

  2007cited by this paper
• An optical neural interface: in vivo control of rodent motor cortex with integrated fiberoptic and optogenetic technology

  2007cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.

  2006cited by this paper
• Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.

  2005cited by this paper
• Classic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTP

  2004cited by this paper
• A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

  2003cited by this paper
• Neural stem cell therapy for neurological diseases: dreams and reality

  2002cited by this paper
• Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease

  2002cited by this paper
• Dyskinesias following neural transplantation in Parkinson's disease

  2002cited by this paper
• Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

  2001cited by this paper
• Clinical observations after neural transplantation in Parkinson's disease.

  2000cited by this paper
• 7-Methyl-6,7,8,9,14,15-hexahydro-5H-benz[d]indolo[2,3-g]azecine: a new heterocyclic system and a new lead compound for dopamine receptor antagonists.

  2000cited by this paper
• Embryonic stem cell lines derived from human blastocysts.

  1998cited by this paper
• Rapid formation of clozapine in guinea-pigs and man following clozapine-N-oxide administration.

  1994cited by this paper

• Transcriptional code for circuit integration in the injured brain by transplanted human neurons.

  2026cites this paper
• Alleviation of mutant TDP-43-mediated neuropathology by inducible stem cells in monkeys

  2026cites this paper
• Current therapeutic strategies in Parkinson’s disease: Future perspectives

  2025cites this paper
• Chemogenetic Activation of Oligodendrocytes Delays Postnatal Myelination by Promoting Progenitor Proliferation and Inhibiting Maturation

  2025cites this paper
• 3D-generation of high-purity midbrain dopaminergic progenitors and lineage-guided refinement of grafts supports Parkinson's disease cell therapy.

  2025cites this paper
• Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson’s disease: Insights from non-human primate studies

  2025cites this paper
• Stem cell repair strategies for epilepsy

  2025cites this paper
• CRISPR Technology in Disease Management: An Updated Review of Clinical Translation and Therapeutic Potential

  2025cites this paper
• RAG recombinase expression discriminates the development of natural killer cells

  2025cites this paper
• Orexin Restoration in Narcolepsy: Breakthroughs in Cellular Therapy

  2025cites this paper
• Human stem cell-derived A10 dopaminergic neurons specifically integrate into mouse circuits and improve depression-like behaviors.

  2025cites this paper
• Forebrain neural progenitors effectively integrate into host brain circuits and improve neural function after ischemic stroke

  2025cites this paper
• CNO induced Ca2+ store and glutamate-dependent nonspecific Ca2+ signalling in DREADD-free brain slices.

  2025cites this paper
• Engineering of rhesus monkey pluripotent stem cells for noninvasive survey and remote control after brain allotransplantation

  2024influential citation
• Dopaminergic Cell Replacement for Parkinson’s Disease: Addressing the Intracranial Delivery Hurdle

  2024cites this paper
• Mild hypothermia promotes neuronal differentiation of human neural stem cells via RBM3-SOX11 signaling pathway

  2024cites this paper
• Circuit integration by transplanted human neurons.

  2024cites this paper
• A systematic review of progenitor survival and maturation in Parkinsonian models

  2024cites this paper
• Introduction to stem cell biology and its role in treating neurologic disorders.

  2024cites this paper
• Autologous vs heterologous cell replacement strategies for Parkinson disease and other neurologic diseases.

  2024cites this paper
• Modulation of human induced neural stem cell-derived dopaminergic neurons by DREADD reveals therapeutic effects on a mouse model of Parkinson’s disease

  2024influential citation
• Generation of human region-specific brain organoids with medullary spinal trigeminal nuclei.

  2024cites this paper
• Stem cell therapeutics and gene therapy for neurologic disorders

  2024cites this paper
• iPS cell therapy 2.0: Preparing for next‐generation regenerative medicine

  2024cites this paper
• Past, present, and future of cell replacement therapy for parkinson’s disease: a novel emphasis on host immune responses

  2024cites this paper
• Some Novel Therapies in Parkinson’s Disease: A Promising Path Forward or Not Yet? A Systematic Review of the Literature

  2024cites this paper
• Human stem cell transplantation for Parkinson’s disease: A systematic review of in situ survival and maturation of progenitors derived from human embryonic or induced stem cells in Parkinsonian models

  2024cites this paper
• Clinical translation of pluripotent stem cell-based therapies: successes and challenges

  2024cites this paper
• Structural and functional integration of human forebrain organoids with the injured adult rat visual system.

  2023cites this paper
• Enhanced production of mesencephalic dopaminergic neurons from lineage-restricted human undifferentiated stem cells

  2023cites this paper
• Human Embryonic Stem Cell-Derived Immature Midbrain Dopaminergic Neurons Transplanted in Parkinsonian Monkeys

  2023cites this paper
• Recent approaches in regenerative medicine in the fight against neurodegenerative disease.

  2023cites this paper
• Modeling of intramembranous ossification using human pluripotent stem cell-derived paraxial mesoderm derivatives

  2023cites this paper
• Midbrain organoids—development and applications in Parkinson’s disease

  2023cites this paper
• Expression of Stro-1, Runx-2, Osterix, and Alp in Alveolar Bone Regeneration Process Following the Administration of Hydroxyapatite Gypsum Puger (HAGP) Scaffold

  2023cites this paper
• Directional induction of neural stem cells, a new therapy for neurodegenerative diseases and ischemic stroke

  2023cites this paper
• iPSCs-Derived Neurons and Brain Organoids from Patients.

  2023cites this paper
• One-step cell biomanufacturing platform: porous gelatin microcarrier beads promote human embryonic stem cell-derived midbrain dopaminergic progenitor cell differentiation in vitro and survival after transplantation in vivo

  2023cites this paper
• Cell replacement for Parkinson’s disease: advances and challenges

  2023cites this paper
• Immortal orexin cell transplants restore motor-arousal synchrony during cataplexy.

  2023cites this paper
• Application of Human Stem Cells to Model Genetic Sensorineural Hearing Loss and Meniere Disease

  2023cites this paper
• Mapping of clonal lineages across developmental stages in human neural differentiation.

  2023cites this paper
• Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson’s Disease

  2023cites this paper
• Functional reconstruction of the basal ganglia neural circuit by human striatal neurons in hypoxic–ischaemic injured brain

  2022cites this paper
• Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells

  2022cites this paper
• A Comprehensive Review on Barium Titanate Nanoparticles as a Persuasive Piezoelectric Material for Biomedical Applications: Prospects and Challenges.

  2022cites this paper
• Challenges in progressing cell therapies to the clinic for Huntington's disease: A review of the progress made with pluripotent stem cell derived medium spiny neurons.

  2022cites this paper
• Assessment of the anti-nociceptive effects of fetal ventral mesencephalic tissue allografts in a rat model of hemi-Parkinson’s disease using fMRI

  2022cites this paper
• 1140Clinical Considerations in Parkinson's Disease Cell Therapy.

  2022cites this paper
• Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury

  2022cites this paper
• Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy

  2022cites this paper
• Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease

  2022cites this paper
• Grafted hPSC-derived GABA-ergic interneurons regulate seizures and specific cognitive function in temporal lobe epilepsy

  2022cites this paper
• Emerging Methods in Modeling Brain Development and Disease with Human Pluripotent Stem Cells.

  2022cites this paper
• Human midbrain dopaminergic neuronal differentiation markers predict cell therapy outcomes in a Parkinson’s disease model

  2022cites this paper
• Dysfunction of vesicular storage in young-onset Parkinson's patient-derived dopaminergic neurons and organoids revealed by single cell electrochemical cytometry

  2022cites this paper
• Assessing Gq-GPCR–induced human astrocyte reactivity using bioengineered neural organoids

  2022cites this paper
• Narrative review of stem cell therapy for ischemic brain injury

  2021cites this paper
• A novel two-factor monosynaptic TRIO tracing method for assessment of circuit integration of hESC-derived dopamine transplants

  2021cites this paper
• CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders

  2021cites this paper
• Differentiation of Human Pluripotent Stem Cells Into Specific Neural Lineages

  2021cites this paper
• Biomaterial Strategies for Restorative Therapies in Parkinson's Disease.

  2021cites this paper
• Progress in generating iPSC-derived dopaminergic neurons as accurate models of neurodegenerative disease

  2021cites this paper
• Generation of hiPSC-Derived Functional Dopaminergic Neurons in Alginate-Based 3D Culture

  2021cites this paper
• Reprogramming Glial Cells into Functional Neurons for Neuro-regeneration: Challenges and Promise

  2021cites this paper
• Trophoblast glycoprotein is a marker for efficient sorting of ventral mesencephalic dopaminergic precursors derived from human pluripotent stem cells

  2021cites this paper
• Bringing Advanced Therapies for Parkinson’s Disease to the Clinic: The Scientist’s Perspective

  2021cites this paper
• iPSCs and cell therapy for Parkinson’s disease

  2021cites this paper
• Dopamine Cell Therapy: From Cell Replacement to Circuitry Repair

  2021cites this paper
• Human spinal GABA neurons alleviate spasticity and improve locomotion in rats with spinal cord injury.

  2021cites this paper
• Chemogenetics as a neuromodulatory approach to treating neuropsychiatric diseases and disorders.

  2021cites this paper
• Cell transplantation therapy for Parkinson's disease

  2020cites this paper
• Bioluminescence‐driven optogenetic activation of transplanted neural precursor cells improves motor deficits in a Parkinson's disease mouse model

  2020cites this paper
• The future of stem cell therapies for Parkinson disease

  2020cites this paper
• Plasticity of Synaptic Transmission in Human Stem Cell-Derived Neural Networks

  2020cites this paper
• Transsynaptic tracing and its emerging use to assess graft‐reconstructed neural circuits

  2020cites this paper
• Deconstructing Neurogenesis, Transplantation and Genome-Editing as Neural Repair Strategies in Brain Disease

  2020cites this paper
• Human Pluripotent Stem Cells and Neural Regeneration

  2020cites this paper
• Next-generation stem cells — ushering in a new era of cell-based therapies

  2020cites this paper
• Glia-to-Neuron Conversion by CRISPR-CasRx Alleviates Symptoms of Neurological Disease in Mice.

  2020cites this paper
• Therapeutic Reversal of Chemically Induced Parkinson Disease by Converting Astrocytes into Nigral Neurons

  2020cites this paper
• Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinson’s disease

  2020cites this paper
• Progress in Modeling and Targeting Inner Ear Disorders with Pluripotent Stem Cells

  2020cites this paper
• Neuronal Replacement as a Tool for Basal Ganglia Circuitry Repair: 40 Years in Perspective

  2020cites this paper
• Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD

  2020cites this paper
• Toward Generating Subtype-Specific Mesencephalic Dopaminergic Neurons in vitro

  2020cites this paper
• Reversing Parkinson Disease Model with in situ Converted Nigral Neurons

  2020cites this paper
• In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons.

  2020cites this paper
• Pluripotent Stem Cell Therapies for Parkinson Disease: Present Challenges and Future Opportunities

  2020cites this paper
• Human Stem Cell-Derived Neurons Repair Circuits and Restore Neural Function.

  2020influential citation
• Characterization of Brevibacillus laterosporus Cas9 (BlatCas9) for Mammalian Genome Editing

  2020cites this paper
• Stem Cell-Based Therapies for Parkinson Disease

  2020cites this paper
• Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.

  2020cites this paper
• Clinically compatible differentiation protocol for human pluripotent stem cell-derived dopaminergic progenitor cells

  2020cites this paper
• Stepwise Protocols for Converting Astrocytes to Neurons in vitro and in Mouse Brain by Depleting Polypyrimidine Tract Binding Protein PTB

  2020cites this paper
• Reversing a model of Parkinson's disease with in situ converted nigral neurons.

  2020cites this paper
• Single cell transcriptomics identifies stem cell-derived graft composition in a model of Parkinsonâ€TMs disease

  2020cites this paper
• Non-engineered and Engineered Adult Neurogenesis in Mammalian Brains

  2019influential citation
• Investigating Brain Repair and Development Using Stem Cells

  2019cites this paper
• Induced pluripotent stem cell‐based modeling of mutant LRRK2‐associated Parkinson's disease

  2019cites this paper